News

‘Landmark moment’ as new pill approved for common type of advanced breast cancer
The Institute of Cancer Research, London, which helped develop the drug, welcomed the move. | ITV National News ...
Thousands of women to benefit from twice-a-day pill for most common breast cancer in what scientists describe as a 'landmark moment'
Results from a clinical trial showed that capivasertib plus the hormone therapy fulvestrant increased the time before the ...
Apple, McDonald’s, Amazon and Coca-Cola Top OAAA’s 2024 MegaBrands Report as Out of Home Advertising Surges
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Virginia Business7h
U.Va. hires AstroZeneca exec to lead Manning biotech institute
Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...
HealthDay on MSN9h
One in 10 With Substance Use Disorder Report Past-Year Hospitalizations
About one in 10 U.S. adults with substance use disorder (SUD) report past-year hospitalizations, according to a research ...
News Nation on MSN4h
Does high cholesterol cause heart disease?
High cholesterol is often the result of lifestyle factors like not getting enough exercise and eating a diet high in ...